Search company, investor...

SUMGEN

sumgenbio.com

Total Raised

$71.02M

Investors Count

Funding, Valuation & Revenue

4 Fundings

SUMGEN has raised $71.02M over 4 rounds.

SUMGEN's latest funding round was a Series B - II for $31.38M on December 30, 2021.

Date	Round	Amount	Investors	Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.	Revenue	Sources
12/30/2021	Series B - II	$31.38M	Addor Capital, Hankang Equity Investment Management, Junchuan Capital, Sinopharm National Vaccine & Serum Institute, Wanhui Capital, Wuxi Shangtong, and ZheShang Venture Capital	$99M	0 FY undefined	4
9/14/2020	Series B	$99M	Subscribe to see more	$99M	0 FY undefined	10
2/21/2019	Series A - II		Subscribe to see more	$99M	0 FY undefined	10
7/27/2018	Series A	$99M	Subscribe to see more	$99M	0 FY undefined	10

Date	12/30/2021	9/14/2020	2/21/2019	7/27/2018
Round	Series B - II	Series B	Series A - II	Series A
Amount	$31.38M	$99M		$99M
Investors	Addor Capital, Hankang Equity Investment Management, Junchuan Capital, Sinopharm National Vaccine & Serum Institute, Wanhui Capital, Wuxi Shangtong, and ZheShang Venture Capital	Subscribe to see more	Subscribe to see more	Subscribe to see more
Valuation	$99M	$99M	$99M	$99M
Revenue	0 FY undefined	0 FY undefined	0 FY undefined	0 FY undefined
Sources	4	10	10	10

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.

Click Now. Join a live demo

Looking for a leg up on competitive, customer and technology insights?

CB Insights puts confidence and clarity into your most strategic decisions.

See how. Join a demo.

Trusted by the world's smartest companies to:

Predict emerging trends
See competitors' playbooks
Stalk the smart money
Identify tomorrow's challengers
Spot growing industries
Kill analyst data work

Let's see how we can help you!

SUMGEN Investors

13 Investors

SUMGEN has 13 investors. Addor Capital invested in SUMGEN's Series B - II funding round.

First funding	Last Funding	Investor	Rounds	Type	Location
9/14/2020	12/30/2021	Addor Capital	2 Series B, Series B - II (2021)	Venture Capital	China
12/30/2021	12/30/2021	ZheShang Venture Capital	1 Series B - II	Venture Capital	China
12/30/2021	12/30/2021	Wanhui Capital	1 Series B - II	Other	China
00/00/0000	00/00/0000	Junchuan Capital	Subscribe to see more	Private Equity	China
00/00/0000	00/00/0000	Hankang Equity Investment Management	Subscribe to see more	Asset/Investment Management	China

First funding	9/14/2020	12/30/2021	12/30/2021	00/00/0000	00/00/0000
Last Funding	12/30/2021	12/30/2021	12/30/2021	00/00/0000	00/00/0000
Investor	Addor Capital	ZheShang Venture Capital	Wanhui Capital	Junchuan Capital	Hankang Equity Investment Management
Rounds	2 Series B, Series B - II (2021)	1 Series B - II	1 Series B - II	Subscribe to see more	Subscribe to see more
Board Seats
Type	Venture Capital	Venture Capital	Other	Private Equity	Asset/Investment Management
Location	China	China	China	China	China